Phase 2 Clinical Data Highlights: Hemab's Phase 2 study of sutacimig (N=34) is intended to address a profound gap in care for GT as there are currently no effective prophylactic treatment options.

Introduction Cervical cancer screening is a critical preventive measure to reduce the burden of cervical cancer. Yet, ...

Palos Verdes Estates, which has a population of 13,047, was named the state of California's richest small town with a median ...

Data show deep, durable responses in the 50 million cell dose level cohort; initial data suggest substantial early improvement in three patients ...

Discusses Full SUMMIT and Positive APEX Trial Results in Systemic Mastocytosis at ASH Conference December 8, 2025 8:00 ...

The House of Assembly gave the green light for the Bermuda Census to start next May. Jason Hayward, the Minister of Economy ...

Guest Contributors Tahina Montoya is a defense and policy researcher at RAND, and Kelly Atkinson is a political scientist at RAND.

The race, sex and ethnicity data comes after the Trump administration ramped up universities’ admissions reporting ...

The fossil and genetic evidence agree that modern humans originated in Africa. The most genetically diverse human populations ...

Objectives Understanding contextual drivers of family planning is crucial for designing effective, context-specific policies and programmes. This study aimed to assess (1) the extent to which province ...

You may have heard the phrase ‘demographic cliff’ tossed around recently. The phrase inspires fear — a fall from a precipice, a steep drop or a tumble downwards. It could imply a stark reduction and ...